Ming Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ming Li has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
An Lou
School of Stomatology, Hunan University of Chinese Medicine, Changsha, People’s Republic of China
5 shared publicationsLingling Gong
Hunan University of Traditional Chinese Medicine
3 shared publicationsHongtai Pei
Sinopharm Group Hunan Co., Ltd., Changsha, People’s Republic of China
2 shared publicationsJing Zhou
School of Stomatology, Hunan University of Chinese Medicine, Changsha, People’s Republic of China
2 shared publicationsQing Zhao
Changsha Stomatological Hospital, Changsha, Hunan 410004, People's Republic of China; Hunan University of Chinese Medicine Affiliated Stomatological Hospital, Changsha, Hunan 410208, People's Republic of China
2 shared publicationsRuirui Wang
School of Stomatology, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China
2 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Springer Nature in Discover Oncology
Key signaling pathways and targeted therapeutic strategies in oral squamous cell carcinoma: a review
- 29 October 2026
- Published by Springer Nature in Discover Oncology
Open AccessKey signaling pathways and targeted therapeutic strategies in oral squamous cell carcinoma: a review
- Open Access
- 10 October 2026
- Published by Springer Nature in BMC Oral Health
Eosinophilic granulomatosis with polyangiitis (EGPA) with tooth loss: oral features
- 10 October 2026
- Published by Springer Nature in BMC Oral Health
Open AccessEosinophilic granulomatosis with polyangiitis (EGPA) with tooth loss: oral features
- Open Access
- 23 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Patterns and influencing factors of dental implant anxiety in China
To investigate the anxiety pattern and its association with perceived pain at different perioperative stages of dental implant surgeries in China, and identify key influencing factors of anxiety. A prospective observational perioperative study was conducted on 506 implant patients in Changsha Stomatological Hospital from January 2025 to June 2025. Patients assessed their current level of dental anxiety at each of five time points: pre-surgery night (T1), hospital waiting period (T2), local anesthesia administration (T3), implant placement procedure (T4), and post-surgery (T5). Pain perception was evaluated by patients using the Numerical Rating Scale (NRS) on the night before surgery, during surgery, and after surgery. Repeated-measures ANOVA, independent sample t-tests, binary logistic regression, and Kruskal–Wallis test were used for analysis. Anxiety levels peaked at T3 (2.61 ± 0.98) and T4 (2.51 ± 1.05), then decreased significantly at T1 (2.38 ± 1.06), T2 (2.21 ± 0.97), and T5 (1.43 ± 0.72). Predicted pain, intraoperative pain, and postoperative pain were significantly correlated with anxiety. Preoperative pain was not significantly associated with anxiety. Female (OR = 2.60), elderly patients (36–50 years old, OR = 2.40 51–72 years old, OR = 2.19), mandibular implant (OR = 1.81), and bimaxillary implant (OR = 9.63) are factors associated with increased odds of anxiety. The model showed acceptable discrimination (AUC = 0.704, 95% CI 0.658–0.750) and calibration (Hosmer–Lemeshow p = 0.42). Dental anxiety peaks during invasive procedural phases. Gender, age, implant location, and perceived pain degree are key influencing factors. Targeted interventions for high-risk groups and effective pain management can help mitigate anxiety and improve perioperative care quality.
- 23 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessPatterns and influencing factors of dental implant anxiety in China
To investigate the anxiety pattern and its association with perceived pain at different perioperative stages of dental implant surgeries in China, and identify key influencing factors of anxiety. A prospective observational perioperative study was conducted on 506 implant patients in Changsha Stomatological Hospital from January 2025 to June 2025. Patients assessed their current level of dental anxiety at each of five time points: pre-surgery night (T1), hospital waiting period (T2), local anesthesia administration (T3), implant placement procedure (T4), and post-surgery (T5). Pain perception was evaluated by patients using the Numerical Rating Scale (NRS) on the night before surgery, during surgery, and after surgery. Repeated-measures ANOVA, independent sample t-tests, binary logistic regression, and Kruskal–Wallis test were used for analysis. Anxiety levels peaked at T3 (2.61 ± 0.98) and T4 (2.51 ± 1.05), then decreased significantly at T1 (2.38 ± 1.06), T2 (2.21 ± 0.97), and T5 (1.43 ± 0.72). Predicted pain, intraoperative pain, and postoperative pain were significantly correlated with anxiety. Preoperative pain was not significantly associated with anxiety. Female (OR = 2.60), elderly patients (36–50 years old, OR = 2.40 51–72 years old, OR = 2.19), mandibular implant (OR = 1.81), and bimaxillary implant (OR = 9.63) are factors associated with increased odds of anxiety. The model showed acceptable discrimination (AUC = 0.704, 95% CI 0.658–0.750) and calibration (Hosmer–Lemeshow p = 0.42). Dental anxiety peaks during invasive procedural phases. Gender, age, implant location, and perceived pain degree are key influencing factors. Targeted interventions for high-risk groups and effective pain management can help mitigate anxiety and improve perioperative care quality.
- Open Access
- 30 April 2026
- Published by Springer Nature in Research Square
Dentists’ Knowledge, Attitude and Practice To China’s Centralized Dental Implants Procurement: A Cross-sectional Study
Background The Chinese government implemented the National Centralized Dental Implants Procurement (NCDIP) policy in September 2022 to enhance the accessibility and quality of dental services and to support the sustainable development of the dental implant industry. In this study, dentists’ knowledge, attitudes, and practices (KAP) regarding the NCDIP were assessed; the implementation of the policy was evaluated; factors influencing KAP were identified; and recommendations were proposed to inform policy refinement and enforcement. Methods A cross-sectional study was conducted in China between May and June 2023 to assess licensed dentists’ knowledge, attitudes, and practices regarding the NCDIP policy using an online survey. Logistic regression analyses were performed to identify factors associated with dentists’ KAP. Results A total of 1,153 dentists completed the survey. Overall, 97.79% of respondents reported awareness of the NCDIP policy, and 71.18% reported being familiar with it. Female dentists demonstrated a higher level of understanding of the policy than male dentists. Among respondents, 79.53% believed that the NCDIP policy could influence healthcare reform, and 75.04% agreed that its implementation was reasonable and could reduce the cost of dental implants. Additionally, 69.32% of dentists believed that the policy could reduce the economic burden on patients, with dentists working in private hospitals reporting stronger perceptions of the policy's impact. Regarding practice, 88.2% of dentists reported prioritizing centrally procured implants, 90.8% reported actively seeking information about the policy, and 90.8% reported actively promoting the policy to patients. Furthermore, 80.14% indicated that they or their family members would choose implants procured through national centralized purchasing. Higher educational attainment was associated with a greater likelihood of choosing centralized procurement, while employment in private hospitals was associated with increased willingness to learn about and promote the policy. Conclusions Overall, most dentists demonstrated adequate understanding of and support for the NCDIP policy; however, further efforts are required to strengthen its promotion and enforcement, particularly in public hospitals, to ensure consistent adherence.
- 30 April 2026
- Published by Springer Nature in Research Square
Open AccessDentists’ Knowledge, Attitude and Practice To China’s Centralized Dental Implants Procurement: A Cross-sectional Study
Background The Chinese government implemented the National Centralized Dental Implants Procurement (NCDIP) policy in September 2022 to enhance the accessibility and quality of dental services and to support the sustainable development of the dental implant industry. In this study, dentists’ knowledge, attitudes, and practices (KAP) regarding the NCDIP were assessed; the implementation of the policy was evaluated; factors influencing KAP were identified; and recommendations were proposed to inform policy refinement and enforcement. Methods A cross-sectional study was conducted in China between May and June 2023 to assess licensed dentists’ knowledge, attitudes, and practices regarding the NCDIP policy using an online survey. Logistic regression analyses were performed to identify factors associated with dentists’ KAP. Results A total of 1,153 dentists completed the survey. Overall, 97.79% of respondents reported awareness of the NCDIP policy, and 71.18% reported being familiar with it. Female dentists demonstrated a higher level of understanding of the policy than male dentists. Among respondents, 79.53% believed that the NCDIP policy could influence healthcare reform, and 75.04% agreed that its implementation was reasonable and could reduce the cost of dental implants. Additionally, 69.32% of dentists believed that the policy could reduce the economic burden on patients, with dentists working in private hospitals reporting stronger perceptions of the policy's impact. Regarding practice, 88.2% of dentists reported prioritizing centrally procured implants, 90.8% reported actively seeking information about the policy, and 90.8% reported actively promoting the policy to patients. Furthermore, 80.14% indicated that they or their family members would choose implants procured through national centralized purchasing. Higher educational attainment was associated with a greater likelihood of choosing centralized procurement, while employment in private hospitals was associated with increased willingness to learn about and promote the policy. Conclusions Overall, most dentists demonstrated adequate understanding of and support for the NCDIP policy; however, further efforts are required to strengthen its promotion and enforcement, particularly in public hospitals, to ensure consistent adherence.
- 17 February 2026
- Published by Elsevier in Tissue and Cell
- Vol. 100, 103398
The role and molecular mechanism of Shikonin in promoting odontogenic differentiation of human dental pulp stem cells
- 17 February 2026
- Published by Elsevier in Tissue and Cell
- Vol. 100, 103398
The role and molecular mechanism of Shikonin in promoting odontogenic differentiation of human dental pulp stem cells
- 3 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 4376-4387
Zero-Shot Capillary Segmentation in Dermoscopy Images via SAM2: A Case Study on Oral Mucosa
Morphological changes in oral mucosal microvasculature serve as early diagnostic markers for various diseases. However, existing dermoscopy image analysis relies heavily on physician expertise, leading to high subjectivity and low efficiency. This paper proposes a zero-shot capillary segmentation method for oral mucosa based on Segment Anything Model 2 (SAM2), which effectively handles reflection artifacts and highlights minute vascular structures through a multi-scale adaptive enhancement algorithm. The method employs a morphology-aware automatic prompt annotation strategy to generate composite guidance containing bounding boxes, foreground points, and background points for SAM2. Without requiring annotated data or model training, this approach achieves precise instance segmentation of capillaries through an “enhancement-annotation-segmentation” collaborative paradigm. On a clinical dataset comprising 212 dermoscopy images from 106 subjects, our method achieved a Dice coefficient of 0.7278 and an IoU of 0.5721, representing improvements of 17.12% and 26.9% respectively compared to the medical-specific baseline MedSAM. This provides an objective auxiliary diagnostic method for oral mucosal diseases that depend on capillary morphology analysis.
- 3 November 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 30 (5) , 4376-4387
Zero-Shot Capillary Segmentation in Dermoscopy Images via SAM2: A Case Study on Oral Mucosa
Morphological changes in oral mucosal microvasculature serve as early diagnostic markers for various diseases. However, existing dermoscopy image analysis relies heavily on physician expertise, leading to high subjectivity and low efficiency. This paper proposes a zero-shot capillary segmentation method for oral mucosa based on Segment Anything Model 2 (SAM2), which effectively handles reflection artifacts and highlights minute vascular structures through a multi-scale adaptive enhancement algorithm. The method employs a morphology-aware automatic prompt annotation strategy to generate composite guidance containing bounding boxes, foreground points, and background points for SAM2. Without requiring annotated data or model training, this approach achieves precise instance segmentation of capillaries through an “enhancement-annotation-segmentation” collaborative paradigm. On a clinical dataset comprising 212 dermoscopy images from 106 subjects, our method achieved a Dice coefficient of 0.7278 and an IoU of 0.5721, representing improvements of 17.12% and 26.9% respectively compared to the medical-specific baseline MedSAM. This provides an objective auxiliary diagnostic method for oral mucosal diseases that depend on capillary morphology analysis.
- Open Access
- 26 September 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-9
Effect of preoperative antibiotic use on the implant success rate: a retrospective cohort study of cefixime and ornidazole in China
This study aims to enhance the current clinical understanding of prophylactic antibiotic treatment in China before implant surgeries, and improve the experience and adherence of patients who undergo implant procedures. Patients eligible for inclusion in the past six years were divided into two groups of 500 patients each. Patients in the medication group received one 500 mg cefixime tablet and one 500 mg ornidazole tablet 0.5 hours before implantation. Patients in the non-medicated group did not receive any medicine. Patients were evaluated at two follow-ups: 7–14 days and 3–6 months after implant surgeries. The primary outcome was implant failure, which was characterized as implant detachment or complete loss during follow-ups, implant mobility (clinical mobility >1 mm) detected by surgeons when manually tightening abutments at the second follow-up (3–6 months after surgeries), or complications requiring clinical intervention occurred, including peri-implant bone resorption exceeding acceptable levels. Secondary outcomes were postoperative infection and adverse events. We statistically analyzed study outcomes using the Pearson Chi-square test, Fisher's exact test, and a multiple logistic regression model to evaluate differences between the two groups. P values less than 0.05 or 95% confidence intervals of relative risk or odds ratio values excluding one were considered statistically significant. We noted implant failures (medication group: four patients, 0.8% and non-medicated group: three patients, 0.6%) and postoperative infections (medication group: 23 patients, 4.6% and non-medicated group: 25 patients, 5.0%) were no statistically significant difference between the two groups. However, adverse events showed a statistically significant increase in the medication group (medication group: 111 patients, 22.2% and non-medicated group: 21 patients, 4.2%), including nausea, vomiting, hypersomnia, dizziness, and diarrhea. There was a statistically non-significant increase in fever in the non-medicated group. No statistically significant evidence existed in preventing postoperative infection between the two groups across smoking status, age, implant system, number of implants (1, 2–3, and ≥4), sinus elevation surgery, implant placement, and guided bone regeneration surgery. Antibiotic prophylaxis using ornidazole in conjunction with cefixime in implant surgery may not have clinical benefits but significantly increases adverse events. Therefore, the necessity of prophylactic antibiotic use in healthy patients before implant surgeries needs to be reconsidered.
- 26 September 2025
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-9
Open AccessEffect of preoperative antibiotic use on the implant success rate: a retrospective cohort study of cefixime and ornidazole in China
This study aims to enhance the current clinical understanding of prophylactic antibiotic treatment in China before implant surgeries, and improve the experience and adherence of patients who undergo implant procedures. Patients eligible for inclusion in the past six years were divided into two groups of 500 patients each. Patients in the medication group received one 500 mg cefixime tablet and one 500 mg ornidazole tablet 0.5 hours before implantation. Patients in the non-medicated group did not receive any medicine. Patients were evaluated at two follow-ups: 7–14 days and 3–6 months after implant surgeries. The primary outcome was implant failure, which was characterized as implant detachment or complete loss during follow-ups, implant mobility (clinical mobility >1 mm) detected by surgeons when manually tightening abutments at the second follow-up (3–6 months after surgeries), or complications requiring clinical intervention occurred, including peri-implant bone resorption exceeding acceptable levels. Secondary outcomes were postoperative infection and adverse events. We statistically analyzed study outcomes using the Pearson Chi-square test, Fisher's exact test, and a multiple logistic regression model to evaluate differences between the two groups. P values less than 0.05 or 95% confidence intervals of relative risk or odds ratio values excluding one were considered statistically significant. We noted implant failures (medication group: four patients, 0.8% and non-medicated group: three patients, 0.6%) and postoperative infections (medication group: 23 patients, 4.6% and non-medicated group: 25 patients, 5.0%) were no statistically significant difference between the two groups. However, adverse events showed a statistically significant increase in the medication group (medication group: 111 patients, 22.2% and non-medicated group: 21 patients, 4.2%), including nausea, vomiting, hypersomnia, dizziness, and diarrhea. There was a statistically non-significant increase in fever in the non-medicated group. No statistically significant evidence existed in preventing postoperative infection between the two groups across smoking status, age, implant system, number of implants (1, 2–3, and ≥4), sinus elevation surgery, implant placement, and guided bone regeneration surgery. Antibiotic prophylaxis using ornidazole in conjunction with cefixime in implant surgery may not have clinical benefits but significantly increases adverse events. Therefore, the necessity of prophylactic antibiotic use in healthy patients before implant surgeries needs to be reconsidered.
- Open Access
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 110-121
Targeting the BMI1-Noxa axis by Dioscin induces apoptosis in oral squamous cell carcinoma cells
Dioscin is a natural plant-derived steroidal saponin that exerts antitumor effects in multiple cancers. It is widely involved in multiple apoptotic pathways and exerts its anti-tumor effects. In this study, we discovered that Dioscin treatment increased the expression of Noxa, thereby inducing the apoptosis of OSCC cells. Previous reports indicate that dysfunction of the BMI1-Noxa axis is frequently observed in multiple cancers. Our study revealed that Dioscin upregulates Noxa by impairing the protein expression of BMI1 in OSCC cells. Dioscin promotes the ubiquitination of BMI1 and facilitates its degradation, leading to upregulation of Noxa expression at the mRNA level and activation of apoptosis. Additionally, Dioscin exhibited potent tumor suppression in xenograft tumor models. In conclusion, our research provides new insights and strategies for inhibiting OSCC cells by investigating the ant-tumor mechanism of the natural compound Dioscin.
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 110-121
Open AccessTargeting the BMI1-Noxa axis by Dioscin induces apoptosis in oral squamous cell carcinoma cells
Dioscin is a natural plant-derived steroidal saponin that exerts antitumor effects in multiple cancers. It is widely involved in multiple apoptotic pathways and exerts its anti-tumor effects. In this study, we discovered that Dioscin treatment increased the expression of Noxa, thereby inducing the apoptosis of OSCC cells. Previous reports indicate that dysfunction of the BMI1-Noxa axis is frequently observed in multiple cancers. Our study revealed that Dioscin upregulates Noxa by impairing the protein expression of BMI1 in OSCC cells. Dioscin promotes the ubiquitination of BMI1 and facilitates its degradation, leading to upregulation of Noxa expression at the mRNA level and activation of apoptosis. Additionally, Dioscin exhibited potent tumor suppression in xenograft tumor models. In conclusion, our research provides new insights and strategies for inhibiting OSCC cells by investigating the ant-tumor mechanism of the natural compound Dioscin.
- 1 January 2023
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 51 (08) , 2221-2241
Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin
The oncoprotein survivin plays a pivotal role in controlling cell division and preventing apoptosis by inhibiting caspase activation. Its significant contribution to tumorigenesis and therapeutic resistance has been well established. Isoliquiritigenin (ISL), a natural compound, has been recognized for its powerful inhibitory effects against various tumors. However, whether ISL exerts regulatory effects on survivin and its underlying mechanism in oral squamous cell carcinoma (OSCC) remains unclear. Here, we found that ISL inhibited the viability and colony formation of OSCC, and promoted their apoptosis. The immunoblotting data showed that ISL treatment significantly decreased survivin expression. Mechanistically, ISL suppressed survivin phosphorylation on Thr34 by deregulating Akt-Wee1-CDK1 signaling, which facilitated survivin for ubiquitination degradation. ISL inhibited CAL27 tumor growth and decreased p-Akt and survivin expression in vivo. Meanwhile, survivin overexpression caused cisplatin resistance of OSCC cells. ISL alone or combined with cisplatin overcame chemoresistance in OSCC cells. Overall, our results revealed that ISL exerted potent inhibitory effects via inducing Akt-dependent survivin ubiquitination in OSCC cells.
- 1 January 2023
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 51 (08) , 2221-2241
Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin
The oncoprotein survivin plays a pivotal role in controlling cell division and preventing apoptosis by inhibiting caspase activation. Its significant contribution to tumorigenesis and therapeutic resistance has been well established. Isoliquiritigenin (ISL), a natural compound, has been recognized for its powerful inhibitory effects against various tumors. However, whether ISL exerts regulatory effects on survivin and its underlying mechanism in oral squamous cell carcinoma (OSCC) remains unclear. Here, we found that ISL inhibited the viability and colony formation of OSCC, and promoted their apoptosis. The immunoblotting data showed that ISL treatment significantly decreased survivin expression. Mechanistically, ISL suppressed survivin phosphorylation on Thr34 by deregulating Akt-Wee1-CDK1 signaling, which facilitated survivin for ubiquitination degradation. ISL inhibited CAL27 tumor growth and decreased p-Akt and survivin expression in vivo. Meanwhile, survivin overexpression caused cisplatin resistance of OSCC cells. ISL alone or combined with cisplatin overcame chemoresistance in OSCC cells. Overall, our results revealed that ISL exerted potent inhibitory effects via inducing Akt-dependent survivin ubiquitination in OSCC cells.
- Open Access
- 1 January 2023
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 14 (13) , 2481-2490
Tanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma
Apoptosis alteration is responsible for tumorigenesis and tumor resistance to therapies. The natural product Tanshinone IIA (Tan IIA) exhibits potent inhibitory effects against various tumors. However, the effect of Tan IIA on apoptosis and its underlying mechanism remains elusive in oral squamous cell carcinoma (OSCC). Here, we demonstrated that Tan IIA dose-dependently suppressed cell viability and colony formation in CAL27, SCC4, and SCC25 cells. Moreover, Tan IIA inhibited Akt activation from inducing Foxo3a dephosphorylation and PUMA-mediated apoptosis. PUMA or Foxo3a knockdown compromised the inhibitory effect of Tan IIA on OSCC cells. Tan IIA administration inhibited CAL27-deprived xenograft tumor growth and increased PUMA expression in vivo. Tan IIA synergistically intensified the efficacy of CDDP/5-FU-based chemotherapy on OSCC cells. Overall, our results revealed that Tan IIA exerted potent antitumor effects via promoting PUMA-mediated apoptosis in OSCC cells.
- 1 January 2023
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 14 (13) , 2481-2490
Open AccessTanshinone IIA inhibits cell viability and promotes PUMA-mediated apoptosis of oral squamous cell carcinoma
Apoptosis alteration is responsible for tumorigenesis and tumor resistance to therapies. The natural product Tanshinone IIA (Tan IIA) exhibits potent inhibitory effects against various tumors. However, the effect of Tan IIA on apoptosis and its underlying mechanism remains elusive in oral squamous cell carcinoma (OSCC). Here, we demonstrated that Tan IIA dose-dependently suppressed cell viability and colony formation in CAL27, SCC4, and SCC25 cells. Moreover, Tan IIA inhibited Akt activation from inducing Foxo3a dephosphorylation and PUMA-mediated apoptosis. PUMA or Foxo3a knockdown compromised the inhibitory effect of Tan IIA on OSCC cells. Tan IIA administration inhibited CAL27-deprived xenograft tumor growth and increased PUMA expression in vivo. Tan IIA synergistically intensified the efficacy of CDDP/5-FU-based chemotherapy on OSCC cells. Overall, our results revealed that Tan IIA exerted potent antitumor effects via promoting PUMA-mediated apoptosis in OSCC cells.